With 0.89 million shares changed hands, the volume of the stock remained lighter than its average volume of 8.38 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $0.8492 whereas the lowest price it dropped to was $0.725. The 52-week range on SPRC shows that it touched its highest point at $6.78 and its lowest point at $0.20 during that stretch. It currently has a 1-year price target of $520.00. Beta for the stock currently stands at 0.49.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SPRC was down-trending over the past week, with a drop of -29.22%, but this was up by 197.33% over a month. Three-month performance surged to 237.48% while six-month performance fell -7.65%. The stock lost -82.33% in the past year, while it has gained 110.36% so far this year.
Float and Shares Shorts:
At present, 10.36 million SPRC shares are outstanding with a float of 10.36 million shares on hand for trading. On 2024-12-31, short shares totaled 0.8 million, which was 735.0 higher than short shares on 1732838400. In addition to Mr. Itschak Shrem as the firm’s President & Director, Dr. Adi Zuloff-Shani Ph.D. serves as its Chief Technologies Officer.
Institutional Ownership:
Through their ownership of 0.0173 of SPRC’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential.
Analysts have provided yearly estimates in a range of $0.03038 being high and $0.03038 being low. For SPRC, this leads to a yearly average estimate of $0.03038. Based on analyst estimates, the high estimate for the next quarter is $0 and the low estimate is $0. The average estimate for the next quarter is thus $0.
